Kaoru Yamakawa

Kaoru Yamakawa

Auto-generated profile, based on publicly available information

Kaoru Yamakawa

Department of Otolaryngology, The University of Tokyo, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2024 in Auris Nasus Larynx
Verified
Journal Article
Open access
KYKaoru Yamakawa
Kaoru Yamakawa
HNHironobu Nishijima
Hironobu Nishijima
MKMegumi Koizumi
Megumi Koizumi
Kenji KondoKenji Kondo
Kenji Kondo
To investigate the accurate volume changes in the paranasal sinus and nasal cavity with age development, using three-dimensional (3D) imaging software METHODS: Paranasal sinus and nasal cavity volumes from computed tomography (CT) images in patients aged 0-24 years were measured using a 3D model to examine age-related changes. Paranasal sinus and nasal cavity growth were compared between age groups. Additionally, the correlation between body height and paranasal sinus growth was examined. A total of 139 CT scans from 137 patients were analyzed. Volume growth of maxillary, ethmoidal, sphenoid, frontal sinuses, and nasal cavity was observed until 18, 16, 20, 20, and 22 years, respectively. Maxillary sinus rapidly grew at 2-8 and 9-12 years, ethmoid sinus 2-8 and 13-16 years, sphenoid sinus 5-8 years, frontal sinus 2-10 years, and nasal cavity 7-12 years. The median volume after growth completion for maxillary, ethmoidal, sphenoid, frontal sinuses, and nasal cavities was 21,937 mm³, 4868 mm³, 5870 mm³, 3172 mm³, and 15,555 mm³, respectively. The left-right difference in the nasal cavity volume increased with age. Sinus and nasal cavity growth completion was delayed by 2-4 years compared to general height growth. Growth of the ethmoid, maxillary, sphenoid, frontal sinus, and nasal cavity was completed in approximately 20 years. Compared to the results shown in reports based primarily on 2D measurements, the ethmoid and sphenoid sinuses and nasal cavity were found to continue to grow until older age than previously thought.

19 March 2025 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Open access
Rumi UehaRumi Ueha
Rumi Ueha
MDMaria Angela Dealino
Maria Angela Dealino
MKMisaki Koyama
Misaki Koyama
KYKaoru Yamakawa
Kaoru Yamakawa
NMNaoyuki Matsumoto
Naoyuki Matsumoto
KKKenji Kondo
Kenji Kondo
Objective: To investigate the effects of modified central‐part laryngectomy with pharyngeal space reduction (CPL‐PR) on patients with weak deglutitive pharyngeal contraction, as seen in late‐stage amyotrophic lateral sclerosis (ALS).Study Design: Retrospective case series.Setting: Single‐institution academic center.Methods: Patients with late‐stage ALS confined at The University of Tokyo Hospital between 2019 and March 2024 in whom CPL‐PR had been performed were identified. Patients who had undergone simultaneous pharyngeal flap surgery or had no preoperative high‐resolution manofluorography done were excluded. Preoperatively, penetration‐aspiration scale (PAS) scores were determined via videofluoroscopic swallowing study. Functional oral intake scale (FOIS) scores and high‐resolution manometric parameters were measured and compared preoperatively and postoperatively.Results: Eighteen patients were identified with a median age of 66.5 (interquartile range [IQR]: 58.0‐74.8). The median preoperative PAS score was 7.5 (IQR: 5.5‐8.0), indicating severe dysphagia. There was significant improvement in oral intake status with FOIS scores increasing from 1 (IQR: 1‐1) to 3 (IQR: 2‐3) at 3 months postoperatively (P = .0002). Significant increases in velopharyngeal closure integral (P = .024) and mesohypopharyngeal contractile integral (P = .0001) were observed. Upper esophageal sphincter (UES) resting pressure was reduced (P = .0002), and UES relaxation time was prolonged during swallowing (P < .0001).Conclusion: There were tangible improvements in pharyngeal contraction, UES bolus passage, and oral intake status following CPL‐PR, which contribute to regaining oral intake in late‐stage ALS. CPL‐PR is an option for patients requiring tracheostomy who wish to prevent aspiration and regain their ability to take food orally.

7 June 2025 in The Laryngoscope
Verified
Journal Article
Open access
NMNaoyuki Matsumoto
Naoyuki Matsumoto
SUSatoshi Ueha
Satoshi Ueha
Rumi UehaRumi Ueha
Rumi Ueha
MKMisaki Koyama
Misaki Koyama
KYKaoru Yamakawa
Kaoru Yamakawa
Kenji KondoKenji Kondo
Kenji Kondo
Objectives: Recurrent respiratory papillomatosis (RRP) is caused by human papillomavirus (HPV) types 6 and 11. However, the cellular and molecular mechanisms underlying its pathogenesis remain to be elucidated. Recently, the conditional reprogramming (CR) method, which reprograms epithelial cells to an undifferentiated stem cell state, has been shown to be effective for studying RRP. Here, we investigated the relationship between viral and host gene expression in CR cells and explored the molecular pathogenesis of RRP.Methods: We evaluated the passage capacity and growth rate of CR cells from fresh RRP tissues and adjacent normal tissues from patients with RRP. Furthermore, we performed RNA‐seq analysis of CR cells across multiple passages to characterize the gene expression profiles associated with RRP.Results: RRP‐derived CR cells exhibited greater passage capacity and proliferation rates than adjacent normal tissue‐derived CR cells. HPV6 gene was expressed in all RRP‐derived CR cells and its expression decreased with each passage. We identified three categories of genes correlated with HPV6: inflammatory genes (e.g., CTSS, CFB), oncogenic genes (e.g., CEACAM5, CEACAM6), and glycosylation‐related genes (e.g., ST6GALNAC1, FUT2).Conclusion: HPV6‐induced gene expression signature in infected epithelial cells may play a role in RRP pathogenesis. Further molecular investigations are necessary to determine whether controlling these genes and related factors can control the progression of RRP.Level of Evidence: N/A.

1 January 2021 in Acta Oto-Laryngologica Case Reports
Verified
Journal Article
Open access
KYKaoru Yamakawa
Kaoru Yamakawa
KKKenji Kondo
Kenji Kondo
AUAkihiko Unaki
Akihiko Unaki
HSHideto Saigusa
Hideto Saigusa
KHKyohei Horikiri
Kyohei Horikiri
TYTatsuya Yamasoba
Tatsuya Yamasoba
Gustatory rhinitis is a type of nonallergic, noninflammatory rhinitis. A high incidence of rhinorrhea, including gustatory rhinitis, is reported in patients with Parkinson's disease (PD). Herein, we report a case of gustatory rhinitis in a patient with a parkinsonian variant of multiple system atrophy (MSA-P). A 56-year-old man presented with gustatory rhinorrhea and bilateral copious nasal discharge while eating. Three years before visiting the ear, nose, and throat clinic, he developed Parkinsonism and was suspected of having MSA-P. He underwent posterior nasal neurectomy under endoscopic guidance, but it did not significantly reduce the rhinorrhea during eating. Pathological examination of the mucosa of the inferior turbinate demonstrated minimal inflammatory cellular infiltration. Severe (gustatory) rhinitis may also be a useful biomarker for the diagnosis of synucleinopathies, including PD and MSA, akin to anosmia, which is a well-known biomarker for the early diagnosis of PD.

28 February 2022 in Auris Nasus Larynx
Verified
Journal Article
Closed access
KYKaoru Yamakawa
Kaoru Yamakawa
HNHironobu Nishijima
Hironobu Nishijima
AKAkatsuki Kubota
Akatsuki Kubota
HNHiroya Naruse
Hiroya Naruse
SBShintaro Baba
Shintaro Baba
Tatsuya YamasobaTatsuya Yamasoba
Tatsuya Yamasoba